cell line

DISSECT Method Using PNA-LNA Clamp Improves Detection of EGFR T790m Mutation.

Published June 28, 2013

DISSECT Method Using PNA-LNA Clamp Improves Detection of EGFR T790m Mutation.

PLoS One. 2013; 8(6): e67782
Guha M, Castellanos-Rizaldos E, Makrigiorgos GM

Non-small cell lung cancer (NSCLC) patients treated with small molecule EGFR inhibitors, such as gefitinib, frequently develop… Continue reading →

Proton-Dependent Inhibition of the Cardiac Sodium Channel Nav1.5 by Ranolazine.

Published June 28, 2013

Proton-dependent inhibition of the cardiac sodium channel Nav1.5 by ranolazine.

Front Pharmacol. 2013; 4: 78
Sokolov S, Peters CH, Rajamani S, Ruben PC

Ranolazine is clinically approved for treatment of angina pectoris and is a potential candidate for antiarrhythmic,… Continue reading →

Pakistan’s Drug Problem.

Published June 27, 2013

Pakistan’s drug problem.

Lancet. 2013 Jun 22; 381(9884): 2153-4
Yaqub F

HubMed – drug

Effects of propofol on damage of rat intestinal epithelial cells induced by heat stress and lipopolysaccharides.

Braz J Med Biol Res. 2013 Jun… Continue reading →

Parthenolide Enhances Dacarbazine Activity Against Melanoma Cells.

Published June 27, 2013

Parthenolide enhances dacarbazine activity against melanoma cells.

Anticancer Drugs. 2013 Jun 21;
Koprowska K, Hartman ML, Sztiller-Sikorska M, Czyz ME

Dacarbazine induces a clinical response only in 15% of melanoma patients. New treatment strategies may involve combinations of drugs… Continue reading →

Investigation of the Mechanisms Governing Doxorubicin and Irinotecan Release From Drug-Eluting Beads: Mathematical Modeling and Experimental Verification.

Published June 26, 2013

Investigation of the mechanisms governing doxorubicin and irinotecan release from drug-eluting beads: mathematical modeling and experimental verification.

J Mater Sci Mater Med. 2013 Jun 25;
Biondi M, Fusco S, Lewis AL, Netti PA

Drug-eluting beads (DEBs) are embolising devices… Continue reading →

Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health.

Published June 26, 2013

Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health.

Eur J Integr Med. 2013 Apr 1; 5(2): 126-140
Bell IR, Schwartz GE, Boyer NN, Koithan M, Brooks AJ

Infectious diseases present public health challenges worldwide. An… Continue reading →

Antimicrobial Activity and Probable Mechanisms of Action of Medicinal Plants of Kenya: Withania Somnifera, Warbugia Ugandensis, Prunus Africana and Plectrunthus Barbatus.

Published June 21, 2013

Antimicrobial Activity and Probable Mechanisms of Action of Medicinal Plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatus.

PLoS One. 2013; 8(6): e65619
Mwitari PG, Ayeka PA, Ondicho J, Matu EN, Bii CC

Withania somnifera, Warbugia… Continue reading →

Evaluating Baculovirus as a Vector for Human Prostate Cancer Gene Therapy.

Published June 12, 2013

Evaluating baculovirus as a vector for human prostate cancer gene therapy.

PLoS One. 2013; 8(6): e65557
Swift SL, Rivera GC, Dussupt V, Leadley RM, Hudson LC, Ma de Ridder C, Kraaij R, Burns JE, Maitland NJ, Georgopoulos LJ

Gene… Continue reading →

Scavenger Receptor-AI-Targeted Iron Oxide Nanoparticles for in Vivo MRI Detection of Atherosclerotic Lesions.

Published June 8, 2013

Scavenger Receptor-AI-Targeted Iron Oxide Nanoparticles for In Vivo MRI Detection of Atherosclerotic Lesions.

Arterioscler Thromb Vasc Biol. 2013 Jun 6;
Segers FM, den Adel B, Bot I, van der Graaf LM, van der Veer E, Gonzalez W, Raynal I,… Continue reading →

Impact of Priming the Infusion System on the Performance of Target-Controlled Infusion of Remifentanil.

Published June 7, 2013

Impact of priming the infusion system on the performance of target-controlled infusion of remifentanil.

Korean J Anesthesiol. 2013 May; 64(5): 407-13
Kim JY, Moon BK, Lee JH, Jo YY, Min SK

The start-up behavior of syringe and syringe pump… Continue reading →